Brief: Jacobio Pharmaceuticals Says Co Receives $100 Million Upfront Payment For Jab-23E73
30/03/2026 02:47
March 30 (Reuters) - Jacobio Pharmaceuticals 1167.HK: RECEIVES $100 MILLION UPFRONT PAYMENT FROM ASTRAZENECA FOR JAB-23E73 Further company coverage: 1167.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan